Flow cytometric immunophenotyping (FCI) of lymphoma: Correlation with histopathology and immunohistochemistry

Diagnostic Pathology

Volumn 3, Issue 1, 2008, Pages

  El Sayed, Abeer M ^a   El Borai, Mohammad H ^a   Bahnassy, Abeer A ^a   El Gerzawi, Shadia M S ^a  

^a NATIONAL CANCER INSTITUTE   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 62349115160     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-3-43     Document Type: Article

References (44)

1. Cancer incidence in Oman, 1993-1997. JA Al-Lawati CR Santhosh-Kumar AJ Mohammed MA Jaffer, East Mediterr Health J 1999 5 5 1035 1041 10983545
2. SEER cancer statistics review, 1973-1999. LAG Ries MP Eisner CL Kosary, National Cancer Institute 2002
3. Cancer pathology registry (2003-2004). N Mokhtar I Gouda I Adel, National Cancer Institute - Cairo University 2006
4. A Comparative Study of Frozen-Section Immunoperoxidase and Flow Cytometry for Immunophenotypic Analysis of Lymph Node Biopsies. KW Biesemier GA Dent KB Pryzwansky JD Folds, Clin Diagn Lab Immunol 1994 1 3 299 303 7496966
5. Contribution of flow cytometric immunophenotyping to the evaluation of tissues with suspected lymphoma. CH Dunphy, Cytometry 2000 42 296 306 10.1002/1097-0320(20001015)42:5<296::AID-CYTO7>3.0.CO;2-X 11025488
6. Clinical flow cytometry. Principles and applications. KD Bauer RE Duque TV Shankey, Williams & Wilkins, Baltimore, USA 1993 204 205
7. Immunophaenotyping in the diagnosis of lymphoma. PE Peghini J Fehr, Praxis (Bern 1994) 2004 93 41 1687 1692 10.1024/0369-8394.93.41.1687 15535602
8. Demonstration of a germinal center immunophenotype in lymphomas by immunocytochemistry and flow cytometry. A Jack S Barrans D Blythe A Rawstron, Methods Mol Med 2005 115 65 69 15998963
9. Lymphomas. RC Braylan, Clinical flow cytometry. Principles and application Williams & Wilkins, Baltimore, USA, Bauer KD, Duque RE, Shankey TV, 1993 203 227
10. Optimal number of reagents required to evaluate hematolymphoid neoplasias: Results of an international consensus meeting. RC Braylan A Orfao MJ Borowitz BH Davis, Cytometry 2001 46 23 27 10.1002/1097-0320(20010215)46: 1<23::AID-CYTO1033>3.0.CO;2-Z 11241503
11. Combining fine-needle aspiration and flow cytometric immunophenotyping in evaluation of nodal and extranodal sites for possible lymphoma: a retrograde review. CH Dunphy R Ramos, Diagn Cytopathol 1997 16 3 200 206 10.1002/(SICI)1097-0339(199703)16:3<200::AID-DC2>3.0.CO;2-J 9099538
12. Utilization of fine-needle aspiration cytology and flow cytometry in the diagnosie and subclassification of primary and recurrent lymphoma. NA Young TI Al-Saleem H Ehya MR Smith, Cancer 1998 84 4 252 261 10.1002/(SICI)1097- 0142(19980825)84:4<252::AID-CNCR11>3.0.CO;2-R 9723601
13. Immunophenotypic analysis of simultaneous specimens from different sites from the same patient with malignant lymphoma. M Bangerter A Hildebrand M Griesshammer, Cytopathology 2001 122 3 168 176 10.1046/j.1365-2303.2001.00322.x
14. Introduction to Cell and Tissue Culture: Theory and Technique. JP Mather PE Roberts, Plenum Press, New York 1998 11 14
15. The role of flow cytometry in the diagnosis of lymphoma: a critical analysis. EE Morse HT Yamase BR Greenberg J Sporn, Ann Clin Lab Sci 1994 24 6 11 8147568
16. Contribution of flow cytometric immunophenotyping to the evaluation of tissues with suspected lymphoma. CH Dunphy, Cytometry 2000 42 296 306 10.1002/1097-0320(20001015)42:5<296::AID-CYTO7>3.0.CO;2-X 11025488
17. Routine use of immunophenotype by flow cytometry in tissues with suspected hematological malignancies. A Martinez M Aymerich M Castillo D Colomer B Bellosillo E Campo, Cytometry B Clin Cytom 2003 56 1 8 15 10.1002/cyto.b.10044 14582132
18. Immuno-flow cytometry and cell block immunohistochemistry in the FNA diagnosis of lymphoma: a review of 73 consecutive cases. F Mayall M Dray D Stanley B Harrison R Allen, Clin Pathol 2000 53 451 457 10.1136/jcp.53.6.451
19. Applications of flow cytometry and immunohistochemistry to diagnostic hematopathology. CH Dunphy, Arch Pathol Lab Med 2004 128 9 1004 1022 15335254
20. Clonality assessment of lymphoproliferative disorders by multiparameter flow cytometry of paraffin embedded tissue: An additional diagnostic tool in surgical pathology. MP Leers PH Theunissen FC Ramaekers, Hum Pathol 2000 31 422 427 10.1053/hp.2000.6551 10821487
21. Flow cytometry in hematopathology: A visual approach to data analysis and interpretation. D Nguyen LW Diamond RC Braylan, Williams & Wilkins, USA 2003
22. Flow Cytometry: A Practical Approach. MG Ormerod, Oxford University Press, Oxford 3 2000
23. Understanding sensitivity and specificity with the right side of the brain. TW Loong, BMJ 327 716 719 14512479 10.1136/bmj.327.7417.716
24. Correlation of results of flow cytometry and morphologic findings in the diagnosis of malignant B-cell lymphoma. P Mandakova V Campr R Kodet, Cas Lek Cesk 2003 142 11 651 655 14689823
25. Routine use of immunophenotype by flow cytometry in tissues with suspected hematological malignancies. A Martinez M Aymerich M Castillo D Colomer B Bellosillo E Campo, Cytometry B Clin Cytom 2003 56 1 8 15 10.1002/cyto.b.10044 14582132
26. Fine-needle aspiration biopsy in the diagnosis and classification of primary and recurrent lymphoma: a retrospective analysis of the utility of cytomorphology and flow cytometry. HY Dong NL Harris FI Preffer MB Pitman, Mod Pathol 2001 14 5 472 481 10.1038/modpathol.3880336 11353059
27. Bone marrow infiltration in B-cell non-Hodgkin's lymphomas: comparison between flow cytometry and bone marrow biopsy. G Carulli S Canigiani M Volpini EM Ciancia S Galimberti A Zucca M Petrini, Recenti Prog Med 2005 96 6 284 290 16078757
28. Immuno-flow cytometry and cell block immunohistochemistry in the FNA diagnosis of lymphoma: a review of 73 consecutive cases. F Mayall M Dray D Stanley B Harrison R Allen, Clin Pathol 2000 53 451 457 10.1136/jcp.53.6.451
29. Flow cytometric immunophenotyping in fine-needle aspiration of lymph nodes. J Chung G Gong J Huh SK Khang JY Ro, J Korean Med Sci 1999 14 4 393 400 10485618
30. The T-Cell Activation Markers CD30 and OX40/CD134 Are Expressed in Nonoverlapping Subsets of Peripheral T-Cell Lymphoma. D Jones DM Fletcher K Pulford DM Dorfman, Blood 1999 93 10 3487 3493 10233901
31. Rapid immunotyping of B cell non-Hodpkin's lymphoma by flow cytometry: a comparison with the standard frozen-section method. TE Witzig PM Banks MJ Sienson, Am J Clin Pathol 1990 94 280 286 2204263
32. Concomitant delineation or surface Ig, B-cell differentiation antigens, and HLA-DR on lymphoid proliferations using three color immunocytochemistry. GH Segal MC Edinger M Owen P Lopez, Cytometry 1991 12 350 359 10.1002/cyto. 990120410 1712263
33. Flow cytometric immunophenotyping of non-hodgkin's lymphomas and related disorders. A Tbakhi M Edinger J Myles B Pohlman, Cytometry 1996 25 113 124 10.1002/(SICI)1097-0320(19961001)25:2<113::AID-CYTO1>3.0.CO;2-I 8891441
34. Fine needle aspiration cytology in the investigation of non-Hodgkin's lymphoma. MD Jeffers J Milton R Herriot M McKean, J Clin Pathol 1998 51 189 196 9659258
35. Flow cytometric immunophenotyping including Bcl-2 detection on fine needle aspirates in the diagnosis of reactive lymphadenopathy and non-Hodgkin's lymphoma. E Laane E Tani E Bjorklund G Elmberger H Everaus L Skoog A Porwit-MacDonald, Cytometry B Clin Cytom 2005 64 1 34 42 15669024
36. Contribution of flow cytometry in the diagnosis of cutaneous lymphoid lesions. H Wu M Smith MM Millenson N Nicolaou VM van Deerlin, J Invest Dermatol 2003 121 6 1522 1530 10.1046/j.1523-1747.2003.12631.x 14675205
37. Morphologic, flow cytometric and cytogenetic evaluation of bone marrow involvement in B-cell lymphoma. H Gomyo M Shimoyama K Minagawa K Yakushijin N Urahama, Haematologica 2003 88 12 1358 1365 14687988
38. Fine-needle cytology and flow cytometry immunophenotyping and subclassification of non-hodgkin lymphoma A critical review of 307 cases with technical suggestions. P Zeppa G Marino G Troncone F Fulciniti A De Renzo, Cancer 2004 102 1 55 65 10.1002/cncr.11903 14968418
39. Serous effusions in malignant lymphomas: a review. DK Das, Diagn Cytopathol 2006 34 5 335 347 10.1002/dc.20432 16604559
40. A web-based system for tissue microarray data management. VD Mea I Bin M Pandolfi C Di Loreto, Diagnostic Pathology 2006 1 36 17034635 10.1186/1746-1596-1-36
41. The modern histopathologist: in the changing face of time. B Saikia K Gupta UN Saikia, Diagnostic Pathology 2008 3 25 18534037 10.1186/1746-1596-3-25
42. Sensitivity of an immunoglobulin heavy chain gene polymerase chain reaction primer system for routine diagnosis of lymphomas. RH Haußen C Braun G Mall, Diagnostic Pathology 2007 2 Suppl 1 S7 10.1186/1746-1596-2-S1-S7
43. Immunophenotyping large B-cell lymphomas: Flow cytometric pitfalls, pathologic correlation. CB Heidi IJ Check A Milano, Am J Clin Pathol 2001 116 2 57 62
44. Demonstration of a germinal center immunophenotype in lymphomas by immunocytochemistry and flow cytometry. A Jack S Barrans D Blythe A Rawstron, Methods Mol Med 2005 115 65 69 15998963